FR2414503A1 - Nouveaux carboxamides n-(tetrazol-5-yliques) de prostaglandine et medicament les contenant - Google Patents
Nouveaux carboxamides n-(tetrazol-5-yliques) de prostaglandine et medicament les contenantInfo
- Publication number
- FR2414503A1 FR2414503A1 FR7900857A FR7900857A FR2414503A1 FR 2414503 A1 FR2414503 A1 FR 2414503A1 FR 7900857 A FR7900857 A FR 7900857A FR 7900857 A FR7900857 A FR 7900857A FR 2414503 A1 FR2414503 A1 FR 2414503A1
- Authority
- FR
- France
- Prior art keywords
- class
- carboxamides
- tetrazol
- atom
- prostaglandins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003180 prostaglandins Chemical class 0.000 title abstract 4
- 150000003857 carboxamides Chemical class 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 3
- -1 2-hexyl Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002254 contraceptive effect Effects 0.000 abstract 2
- QDMPKKFNRFFSNK-UHFFFAOYSA-N n-(2h-tetrazol-5-yl)formamide Chemical class O=CNC1=NN=NN1 QDMPKKFNRFFSNK-UHFFFAOYSA-N 0.000 abstract 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical compound NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 abstract 1
- 230000000767 anti-ulcer Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
Abstract
L'invention concerne de nouveaux carboxamides N-(tétrazol-5-yliques) de prostaglandines. Les composés de l'invention entrent dans trois classes de carboxamides N-(tétrazol-5-yliques) de prostaglandines dont les substitutions de la chaîne latérale inferieure consistent en un groupe phényle ou phényle substitué sur l'atome C-16 (classe 1), phénoxy ou phénoxy substitué sur l'atome C-16 (classe 2) et n-pentyle, 2-hexyle ou 2-méthyl-2-hexyle sur l'atome C-15 (classe 3); la synthèse de ces composés a été effectuée en utilisant des composés intermédiaires imidazoliques acylés et le 5-aminotétrazole. Les trois classes de prostaglandines de l'invention ont des activités biologiques sélectives différentes, à savoir une activité anti-ulcéreuse (classe 1), une activité anticonceptionnelle (classe 2) et une activité bronchodilatatrice et anticonceptionnelle (classe 3).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86956978A | 1978-01-16 | 1978-01-16 | |
US89373178A | 1978-04-05 | 1978-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2414503A1 true FR2414503A1 (fr) | 1979-08-10 |
FR2414503B1 FR2414503B1 (fr) | 1981-12-24 |
Family
ID=27128123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7900857A Granted FR2414503A1 (fr) | 1978-01-16 | 1979-01-15 | Nouveaux carboxamides n-(tetrazol-5-yliques) de prostaglandine et medicament les contenant |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS54100378A (fr) |
AR (1) | AR222817A1 (fr) |
AT (1) | AT367755B (fr) |
AU (1) | AU507853B2 (fr) |
CA (1) | CA1152502A (fr) |
CH (1) | CH635833A5 (fr) |
DD (1) | DD141155A5 (fr) |
DE (1) | DE2901476C3 (fr) |
DK (1) | DK523378A (fr) |
ES (1) | ES482421A1 (fr) |
FI (1) | FI790120A (fr) |
FR (1) | FR2414503A1 (fr) |
GB (1) | GB2012272B (fr) |
GR (1) | GR72747B (fr) |
IE (1) | IE48175B1 (fr) |
IL (1) | IL56433A (fr) |
IN (1) | IN150279B (fr) |
IT (1) | IT1110992B (fr) |
LU (1) | LU80789A1 (fr) |
NL (1) | NL7900292A (fr) |
NO (1) | NO790122L (fr) |
NZ (1) | NZ189377A (fr) |
PH (3) | PH15031A (fr) |
PL (1) | PL117869B1 (fr) |
PT (1) | PT69076A (fr) |
SE (1) | SE427657B (fr) |
SU (1) | SU831071A3 (fr) |
YU (1) | YU4579A (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2316924A1 (fr) * | 1975-06-23 | 1977-02-04 | Pfizer | 11-desoxy-16-aryloxy-o-tetranorprostaglandines |
FR2394539A1 (fr) * | 1977-06-13 | 1979-01-12 | Pfizer | Nouveaux derives substitues en position 15 d'o-pentanorprostaglandine et leur utilisation comme medicament |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788209A (fr) * | 1971-09-01 | 1973-02-28 | Pfizer | Derives tetrazoyliques des prostaglandines naturelles |
DD118856A5 (fr) * | 1972-11-08 | 1976-03-20 | ||
DE2559093C3 (de) * | 1975-12-30 | 1981-12-24 | Pfizer Inc., 10017 New York, N.Y. | 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere |
-
1978
- 1978-11-23 IN IN841/DEL/78A patent/IN150279B/en unknown
- 1978-11-23 DK DK523378A patent/DK523378A/da not_active Application Discontinuation
- 1978-12-27 SU SU782715902A patent/SU831071A3/ru active
- 1978-12-27 PL PL1978212183A patent/PL117869B1/pl unknown
- 1978-12-27 DD DD78210198A patent/DD141155A5/de unknown
-
1979
- 1979-01-11 YU YU00045/79A patent/YU4579A/xx unknown
- 1979-01-12 JP JP286979A patent/JPS54100378A/ja active Pending
- 1979-01-12 CA CA000319536A patent/CA1152502A/fr not_active Expired
- 1979-01-12 PH PH22056A patent/PH15031A/en unknown
- 1979-01-15 NL NL7900292A patent/NL7900292A/xx not_active Application Discontinuation
- 1979-01-15 FI FI790120A patent/FI790120A/fi unknown
- 1979-01-15 AU AU43359/79A patent/AU507853B2/en not_active Ceased
- 1979-01-15 IL IL56433A patent/IL56433A/xx unknown
- 1979-01-15 FR FR7900857A patent/FR2414503A1/fr active Granted
- 1979-01-15 LU LU80789A patent/LU80789A1/fr unknown
- 1979-01-15 NZ NZ189377A patent/NZ189377A/xx unknown
- 1979-01-15 GB GB791428A patent/GB2012272B/en not_active Expired
- 1979-01-15 NO NO790122A patent/NO790122L/no unknown
- 1979-01-15 GR GR58098A patent/GR72747B/el unknown
- 1979-01-15 CH CH38079A patent/CH635833A5/fr not_active IP Right Cessation
- 1979-01-15 SE SE7900353A patent/SE427657B/sv not_active IP Right Cessation
- 1979-01-15 PT PT69076A patent/PT69076A/pt unknown
- 1979-01-15 IT IT19290/79A patent/IT1110992B/it active
- 1979-01-15 IE IE60/79A patent/IE48175B1/en unknown
- 1979-01-15 AT AT0027579A patent/AT367755B/de not_active IP Right Cessation
- 1979-01-16 AR AR275174A patent/AR222817A1/es active
- 1979-01-16 DE DE2901476A patent/DE2901476C3/de not_active Expired
- 1979-07-11 ES ES482421A patent/ES482421A1/es not_active Expired
- 1979-11-19 PH PH23299A patent/PH15653A/en unknown
- 1979-11-19 PH PH23301A patent/PH15643A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2316924A1 (fr) * | 1975-06-23 | 1977-02-04 | Pfizer | 11-desoxy-16-aryloxy-o-tetranorprostaglandines |
FR2394539A1 (fr) * | 1977-06-13 | 1979-01-12 | Pfizer | Nouveaux derives substitues en position 15 d'o-pentanorprostaglandine et leur utilisation comme medicament |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE899008A (fr) | Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides | |
DZ490A1 (fr) | Nouveaux dérivés d'acides aminés bicycliques, procédé pour leur préparation, médicaments contenant ces composés et leur utilisation, nouveaux acides aminés bicycliques comme produits intermédiaires etprocédé pour leur préparation. | |
BE901224A (fr) | Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation. | |
FR2359125A1 (fr) | Nouveaux derives de prostaglandine, leur procede de preparation et medicament les contenant | |
FR2394534A1 (fr) | Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes, procedes pour leur preparation et medicaments les renfermant | |
FR2387229A1 (fr) | Dipyrido (4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant | |
DK165982C (da) | Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser | |
BE903846A (fr) | Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation. | |
ES539123A0 (es) | Un compuesto de 3-indolcarboxamida | |
FR2398067A1 (fr) | Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant | |
FR2358415A1 (fr) | Derives peptidiques, leur preparation et leur application en tant que medicaments | |
FR2404005A1 (fr) | Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant | |
FR2367055A1 (fr) | Nouveaux derives d'alcanolamines, leur procede de preparation et composition pharmaceutique les contenant | |
FR2414503A1 (fr) | Nouveaux carboxamides n-(tetrazol-5-yliques) de prostaglandine et medicament les contenant | |
BE900178A (fr) | Urees et thio-urees anti-atherosclerotiques. | |
FR2442844A1 (fr) | Analogues de la prostaglandine i1 et compositions pharmaceutiques les contenant | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
BE903376A (fr) | Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant | |
FR2362828A1 (fr) | Nouve | |
FR2403336A1 (fr) | Derives de 3,4-dihydrocarbostyrile, leur procede de preparation et leur utilisation pour le traitement des troubles cardiaques | |
FR2453152A1 (fr) | Nouveaux derives de prostaglandine et medicament les contenant | |
MA26752A1 (fr) | Composes de quinoleine, leurs preparations et leurs utilisations therapeutiques. | |
FR2378757A1 (fr) | Nor-o-heterocyclo-dehydro-13, 14 prostaglandines, leur procede de preparation et leur application comme medicaments | |
FR2401139A2 (fr) | Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant | |
FR2359154A1 (fr) | Derives peptidiques utiles comme medicaments et procede pour leur preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |